{"status": "ok", "totalResults": 1, "articles": [{"source": {"id": null, "name": "European Pharmaceutical Review"}, "author": null, "title": "Microbiome therapies: a maturing movement - European Pharmaceutical Review", "description": "On WMD 2023, Herv\u00e9 Affagard of MaaT Pharma and Jeffrey Silber of Biosciences delve into the innovative landscape of microbiome therapies.", "url": "https://www.europeanpharmaceuticalreview.com/article/183944/microbiome-therapies-a-maturing-movement/", "urlToImage": "https://www.europeanpharmaceuticalreview.com/wp-content/uploads/microbiome-therapeutics-wmd-2023.jpg", "publishedAt": "2023-06-27T11:02:41Z", "content": "Posted: 27 June 2023 | Catherine Eckford (European Pharmaceutical Review) | No comments yet\r\nOn World Microbiome Day 2023, Herv\u00e9 Affagard, CEO and co-founder of MaaT Pharma and Jeffrey Silber, Chief \u2026 [+14028 chars]"}]}